Greene Barry E 4
4 · Karyopharm Therapeutics Inc. · Filed Aug 15, 2022
Insider Transaction Report
Form 4
Greene Barry E
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-08-11−7,576→ 0 totalExercise: $1.49Exp: 2023-01-20→ Common Stock (7,576 underlying) - Exercise/Conversion
Common Stock
2022-08-11$1.49/sh+7,576$11,250→ 13,606 total
Footnotes (1)
- [F1]This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 14, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.